可变剪接在肌肉发育中的作用研究进展

doi:10.16431/j.cnki.1671-7236.2021.09.011

摘要/Abstract

摘要： 可变剪接发生在DNA转录为前体mRNA后，通过该过程可以使单个基因产生多个mRNA异构体和蛋白质亚型，增加了转录后加工过程中基因的信息多样性和蛋白质丰度。剪接体、剪接因子和其他RNA结合蛋白催化识别剪接位点和可变剪接外显子，参与调节可变剪接，从进化的角度来看，可变剪接在一定程度上为生物进化提供了驱动力。可变剪接作为组织特异性调节剂，参与肌肉发育的整个过程。在成肌细胞分化过程中，多聚嘧啶序列结合蛋白（polypyrimidine tract-binding protein，PTB）和RNA结合蛋白4（RNA-binding motif protein 4，RBM4）分别与原肌球蛋白的内含子多嘧啶序列和富含CU的内含子结合，共同调节α-原肌球蛋白的肌肉细胞特异性外显子选择的活性。RBM4可通过下调PTB表达并颉颃PTB在外显子选择中的活性来协同作用于肌细胞增殖分化的特异性剪接；肌球蛋白Ⅰ亚型通过可变剪接产生4种不同长度杠杆臂的蛋白质，影响肌肉的张力与拉伸激活；可变剪接可能是产生肌肉类型特异性的重要机制，选择性剪接产生具有不同催化动力学的肌球蛋白重链同工型，催化动力学差异地调节收缩性，从而影响肌纤维类型和肌肉功能。作者通过阐述可变剪接事件在肌肉发育及肌纤维形成过程中的主要作用，揭示可变剪接对肌肉发育的作用，以期为后续研究肌肉的发育调控机理提供参考依据。

关键词: 可变剪接; 增殖分化; 肌球蛋白; 肌纤维类型

Abstract: Alternative splicing occurs after DNA is transcribed into precursor mRNA, and multiple mRNA isomers and protein subtypes can be produced from a single gene through this process, which increases the information diversity and protein abundance of genes during post-transcriptional processing. Spliceosomes, splicing factors and other RNA-binding proteins catalyse the recognition of splicing sites and alternative splicing exons, and participate in the regulation of alternative splicing. From the perspective of evolution, alternative splicing provides a driving force for biological evolution to some extent. As a tissue-specific regulator, alternative splicing is involved in the whole process of muscle development. During myoblast differentiation, polypyrimidine tract-binding protein (PTB) and RNA-binding motif protein 4 (RNA-binding motif protein 4, RBM4) binds to the intron polypyrimidine sequence of tropomyosin and the CU-rich intron, respectively, and modulate the activity of muscle cell-specific exon selection of alpha-tropomyosin. RBM4 plays a synergistic role in the specific splicing of muscle cell proliferation and differentiation by down-regulating the expression of PTB and antagonizing the activity of PTB exon selection. Myosin Ⅰ subtype produces proteins of four different length lever arms through alternative splicing, which affect muscle tension and muscle stretching activation. Alternative splicing may be an important mechanism for the generation of muscle type specificity. Selective splicing produces myosin heavy chain isoforms with different catalytic kinetics, which regulate contractiity differently, thus affecting muscle fiber type and muscle function. By expounding the main roles of alternative splicing events in muscle development and muscle fiber formation, the author revealed the role of alternative splicing on muscle development, in the hope of providing a reference for the follow-up research on muscle development regulation mechanism.

Key words: alternative splicing; proliferation and differentiation; myosin; muscle fiber type

中图分类号:

S852.1

周小南, 丁燕玲, 王鹏飞, 赵志艳, 赵磊, 张岩峰, 马应, 康晓龙. 可变剪接在肌肉发育中的作用研究进展[J]. 中国畜牧兽医, 2021, 48(9): 3206-3214.

ZHOU Xiaonan, DING Yanling, WANG Pengfei, ZHAO Zhiyan, ZHAO Lei, ZHANG Yanfeng, MA Ying, KANG Xiaolong. Research Progress on the Role of Alternative Splicing in Muscle Development[J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(9): 3206-3214.

参考文献

[1] WANG Y, WANG Y, LI K, et al. An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors[J]. Bioscience Reports, 2020, 40(10):BSR20202338.
[2] BLENCOWE B J.The relationship between alternative splicing and proteomic complexity[J]. Trends in Biochemical Sciences, 2017, 42(6):407-408.
[3] ZHAO S.Alternative splicing, RNA-seq and drug discovery[J]. Drug Discovery Today, 2019, 24(6):1258-1267.
[4] BARALLE F E, GIUDICE J.Alternative splicing as a regulator of development and tissue identity[J]. Nature Reviews.Molecular Cell Biology, 2017, 18(7):437-451.
[5] KIM H K, PHAM M, KO K S, et al. Alternative splicing isoforms in health and disease[J]. Pflugers Archiv:European Journal of Physiology, 2018, 470(7):995-1016.
[6] XU B, SHI Y, WU Y, et al. Role of RNA secondary structures in regulating Dscam alternative splicing[J]. Biochimica et Biophysica Acta, 2019, 1862(11-12):194381.
[7] JIN Y, DONG H, SHI Y, et al. Mutually exclusive alternative splicing of pre-mRNAs[J]. Wiley Interdisciplinary Reviews.RNA, 2018, 9(3):e1468.
[8] PLASCHKA C, LIN P C, CHARENTON C, et al. Prespliceosome structure provides insights into spliceosome assembly and regulation[J]. Nature, 2018, 559(7714):419-422.
[9] FISZBEIN A, KRICK K S, BEGG B E, et al. Exon-mediated activation of transcription starts[J]. Cell, 2019, 179(7):1551-1565.
[10] WANG Y, LIU J, HUANG B O, et al. Mechanism of alternative splicing and its regulation[J]. Biomedical Reports, 2015, 3(2):152-158.
[11] CHEN M, MANLEY J L.Mechanisms of alternative splicing regulation:Insights from molecular and genomics approaches[J]. Nature Reviews.Molecular Cell Biology, 2009, 10(11):741-754.
[12] BAEZA-CENTURION P, MINANA B, VALCARCEL J, et al. Mutations primarily alter the inclusion of alternatively spliced exons[J]. eLife, 2020, 9:e59959.
[13] RONG S, BUERER L, RHINE C L, et al. Mutational bias and the protein code shape the evolution of splicing enhancers[J]. Nature Communications, 2020, 11(1):2845.
[14] CHEN S Y, LI C, JIA X, et al. Sequence and evolutionary features for the alternatively spliced exons of eukaryotic genes[J]. International Journal of Molecular Sciences, 2019, 20(15):3834.
[15] ROGERS S O.Integrated evolution of ribosomal RNAs, introns, and intron nurseries[J]. Genetica, 2019, 147(2):103-119.
[16] MOVASSAT M, FOROUZMAND E, REESE F, et al. Exon size and sequence conservation improves identification of splice-altering nucleotides[J]. RNA, 2019, 25(12):1793-1805.
[17] GONZALEZ-HILARION S, PAULET D, LEE K T, et al. Intron retention-dependent gene regulation in Cryptococcus neoformans[J]. Scientific Reports, 2016, 6:32252.
[18] POVERENNAYA I V, ROYTBERG M A.Spliceosomal introns:Features, functions, and evolution[J]. Biochemistry.Biokhimiia, 2020, 85(7):725-734.
[19] KEDZIERSKA H, PIEKIELKO-WITKOWSKA A.Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer[J]. Cancer letters, 2017, 396:53-65.
[20] YANG Q, ZHAO J, ZHANG W, et al. Aberrant alternative splicing in breast cancer[J]. Journal of Molecular Cell Biology, 2019, 11(10):920-929.
[21] MELO J P, KALYNA M, DUQUE P.Current challenges in studying alternative splicing in plants:The case of physcomitrella patens SR proteins[J]. Frontiers in Plant Science, 2020, 11:286.
[22] THIJSSEN V L, HEUSSCHEN R, CAERS J, et al. Galectin expression in cancer diagnosis and prognosis:A systematic review[J]. Biochimica et Biophysica Acta, 2015, 1855(2):235-247.
[23] SAHEBI M, HANAFI M M, VAN WIJNEN A J, et al. Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins[J]. Gene, 2016, 587(2):107-119.
[24] WANG Z, XIAO X, VAN NOSTRAND E, et al. General and specific functions of exonic splicing silencers in splicing control[J]. Molecular Cell, 2006, 23(1):61-70.
[25] STEVENS M, OLTEAN S.Modulation of the apoptosis gene Bcl-x function through alternative splicing[J]. Frontiers in Genetics, 2019, 10:804.
[26] DA S M, MOREIRA G A, GONCALVES D S R, et al. Splicing regulators and their roles in cancer biology and therapy[J]. BioMed Research International, 2015, 2015:150514.
[27] LONG Y, SOU W H, YUNG K, et al. Distinct mechanisms govern the phosphorylation of different SR protein splicing factors[J]. The Journal of Biological Chemistry, 2019, 294(4):1312-1327.
[28] DESCHENES M, CHABOT B.The emerging role of alternative splicing in senescence and aging[J]. Aging Cell, 2017, 16(5):918-933.
[29] URBANSKI L M, LECLAIR N, ANCZUKOW O.Alternative-splicing defects in cancer:Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics[J]. Wiley Interdisciplinary Reviews.RNA, 2018, 9(4):e1476.
[30] GEORGE A, AUBOL B E, FATTET L, et al. Disordered protein interactions for an ordered cellular transition:Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate[J]. The Journal of Biological Chemistry, 2019, 294(24):9631-9641.
[31] SAVISAAR R, HURST L D.Purifying selection on exonic splice enhancers in intronless genes[J]. Molecular Biology and Evolution, 2016, 33(6):1396-1418.
[32] NTINI E, MARSICO A.Functional impacts of non-coding RNA processing on enhancer activity and target gene expression[J]. Journal of Molecular Cell Biology, 2019, 11(10):868-879.
[33] AOYAMA Y, SASAI H, ABDELKREEM E, et al. A novel mutation (c.12113 T>A) in the polypyrimidine tract of the splice acceptor site of intron 2 causes exon 3 skipping in mitochondrial acetoacetyl-CoA thiolase gene[J]. Molecular Medicine Reports, 2017, 15(6):3879-3884.
[34] GUEROUSSOV S, WEATHERITT R J, O'HANLON D, et al. Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing[J]. Cell, 2017, 170(2):324-339.
[35] YING Y, WANG X, VUONG C K, et al. Splicing activation by Rbfox requires self-aggregation through its tyrosine-rich domain[J]. Cell, 2017, 170(2):312-323.
[36] SUN W, HU S, HU J, et al. Akirin 1 promotes myoblast differentiation by modulating multiple myoblast differentiation factors[J]. Bioscience Reports, 2019, 39(3):BSR20182152.
[37] 易茜.IGF1剪接变异体IGF1Ec对成肌细胞生物学功能的影响及相关机理研究[D].重庆:重庆大学, 2016. YI Q.Effect of IGF1 splicing isoform IGF1Ec on the biological function of myoblasts and its related mechanism[D].Chongqing:Chongqing University, 2016.(in Chinese)
[38] HU J, QIAN H, XUE Y, et al. PTB/nPTB:Master regulators of neuronal fate in mammals[J]. Biophysics Reports, 2018, 4(4):204-214.
[39] GRABOWSKI P J, BLACK D L.Alternative RNA splicing in the nervous system[J]. Progress in Neurobiology, 2001, 65(3):289-308.
[40] LE SOMMER C, LESIMPLE M, MEREAU A, et al. PTB regulates the processing of a 3'-terminal exon by repressing both splicing and polyadenylation[J]. Molecular and Cellular Biology, 2005, 25(21):9595-9607.
[41] GOODING C, ROBERTS G C, SMITH C W.Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon[J]. RNA, 1998, 4(1):85-100.
[42] LÓPEZ-MARTÍNEZ A, SOBLECHERO-MARTÍN P, DE-LA-PUENTE-OVEJERO L, et al. An overview of alternative splicing defects implicated in myotonic dystrophy type Ⅰ[J]. Genes, 2020, 11(9):1109.
[43] GAZZARA M R, MALLORY M J, ROYTENBERG R, et al. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes[J]. Genome Research, 2017, 27(8):1360-1370.
[44] SUREAU A, SAULIERE J, EXPERT-BEZANCON A, et al. CELF and PTB proteins modulate the inclusion of the beta-tropomyosin exon 6B during myogenic differentiation[J]. Experimental Cell Research, 2011, 317(1):94-106.
[45] LIN J C, YAN Y T, HSIEH W K, et al. RBM4 promotes pancreas cell differentiation and insulin expression[J]. Molecular and Cellular Biology, 2013, 33(2):319-327.
[46] SU C H, HUNG K Y, HUNG S C, et al. RBM4 regulates neuronal differentiation of mesenchymal stem cells by modulating alternative splicing of pyruvate kinase M[J]. Molecular and Cellular Biology, 2017, 37(3):e00466-16.
[47] LU C C, CHEN T H, WU J R, et al. Phylogenetic and molecular characterization of the splicing factor RBM4[J]. PLoS One, 2013, 8(3):e59092.
[48] YANG J, HUNG L H, LICHT T, et al. RBM24 is a major regulator of muscle-specific alternative splicing[J]. Developmental Cell, 2014, 31(1):87-99.
[49] LIN J C, TARN W Y.RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing[J]. The Journal of Cell Biology, 2011, 193(3):509-520.
[50] TAMURA Y.Cross-bridge mechanism of residual force enhancement after stretching in a skeletal muscle[J]. Computer Methods in Biomechanics and Biomedical Engineering, 2018, 21(1):75-82.
[51] ABOELKASSEM Y, TRAYANOVA N.Tropomyosin dynamics during cardiac muscle contraction as governed by a multi-well energy landscape[J]. Progress in Biophysics and Molecular Biology, 2019, 144:102-115.
[52] YAMADA Y, NAMBA K, FUJII T.Cardiac muscle thin filament structures reveal calcium regulatory mechanism[J]. Nature Communications, 2020, 11(1):153.
[53] ZHU Y, ZHANG J W, QI J, et al. Molecular regulation mechanism of Myomaker and Myomerger in myoblast fusion[J]. Yi Chuan, 2019, 41(12):1110-1118.
[54] 孔旭.Rbm24调控心脏肌节组装及与心肌病关系的研究[D].厦门:厦门大学, 2018. KONG X.Rbm24 modulated cardiac segmental assembly and its relationship with cardiomyopathy[D].Xiamen:Xiamen University, 2018.(in Chinese)
[55] LAAKSO J M, LEWIS J H, SHUMAN H, et al. Control of myosin-Ⅰ force sensing by alternative splicing[J]. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(2):698-702.
[56] GHALEB A M, BIALKOWSKA A B, SNIDER A J, et al. IQ motif-containing GTPase-activating protein 2(IQGAP2) is a novel regulator of colonic inflammation in mice[J]. PLoS One, 2015, 10(6):e129314.
[57] SUGI H, CHAEN S, AKIMOTO T.Electron microscopic recording of the power and recovery strokes of individual myosin heads coupled with ATP hydrolysis:Facts and implications[J]. International Journal of Molecular Sciences, 2018, 19(5):1368.
[58] GALLEGO M E, SIRAND-PUGNET P, DUROSAY P, et al. Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA:Positive and negative regulations[J]. Biochimie, 1996, 78(6):457-465.
[59] GALLEGO M E, BALVAY L, BRODY E.cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene[J]. Molecular and Cellular Biology, 1992, 12(12):5415-5425.
[60] LIBRI D, GOUX-PELLETAN M, BRODY E, et al. Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene[J]. Molecular and Cellular Biology, 1990, 10(10):5036-5046.
[61] GALLEGO M E, GATTONI R, STEVENIN J, et al. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A[J]. The EMBO Journal, 1997, 16(7):1772-1784.
[62] EXPERT-BEZANCON A, SUREAU A, DUROSAY P, et al. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B[J]. The Journal of Biological Chemistry, 2004, 279(37):38249-38259.
[63] BAREJA A, HOLT J A, LUO G, et al. Human and mouse skeletal muscle stem cells:Convergent and divergent mechanisms of myogenesis[J]. PLoS One, 2014, 9(2):e90398.
[64] NIKONOVA E, KAO S Y, RAVICHANDRAN K, et al. Conserved functions of RNA-binding proteins in muscle[J]. The International Journal of Biochemistry & Cell Biology, 2019, 110:29-49.
[65] CHARLESTON J S, SCHNELL F J, DWORZAK J, et al. Eteplirsen treatment for Duchenne muscular dystrophy:Exon skipping and dystrophin production[J]. Neurology, 2018, 90(24):e2146-e2154.
[66] RODRIGUEZ J M, POZO F, DI DOMENICO T, et al. An analysis of tissue-specific alternative splicing at the protein level[J]. PLoS Computational Biology, 2020, 16(10):e1008287.
[67] NAKKA K, GHIGNA C, GABELLINI D, et al. Diversification of the muscle proteome through alternative splicing[J]. Skelet Muscle, 2018, 8(1):8.
[68] NIKONOVA E, KAO S Y, SPLETTER M L.Contributions of alternative splicing to muscle type development and function[J]. Seminars in Cell & Developmental Biology, 2020, 104:65-80.
[69] REISER P J, MOSS R L, GIULIAN G G, et al. Shortening velocity in single fibers from adult rabbit soleus muscles is correlated with myosin heavy chain composition[J]. The Journal of Biological Chemistry, 1985, 260(16):9077-9080.
[70] ANDERSON R L, TRIVEDI D V, SARKAR S S, et al. Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers[J]. Proceedings of the National Academy of Sciences of the United States of America, 2018, 115(35):E8143-E8152.
[71] KRONERT W A, MELKANI G C, MELKANI A, et al. Alternative relay and converter domains tune native muscle myosin isoform function in Drosophila[J]. Journal of Molecular Biology, 2012, 416(4):543-557.
[72] YANG C, KAPLAN C N, THATCHER M L, et al. The influence of myosin converter and relay domains on cross-bridge kinetics of Drosophila indirect flight muscle[J]. Biophysical Journal, 2010, 99(5):1546-1555.
[73] MILLER B M, BLOEMINK M J, NYITRAI M, et al. A variable domain near the ATP-binding site in Drosophila muscle myosin is part of the communication pathway between the nucleotide and actin-binding sites[J]. Journal of Molecular Biology, 2007, 368(4):1051-1066.
[74] PANDEY M, STORMO G D, DUTCHER S K.Alternative splicing during the Chlamydomonas reinhardtii cell cycle[J]. G3(Bethesda), 2020, 10(10):3797-3810.
[75] YANG M, SHANG X, ZHOU Y, et al. Full-length transcriptome analysis of Plasmodium falciparum by single-molecule long-read sequencing[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11:631545.
[76] FAIGENBLOOM L, RUBINSTEIN N D, KLOOG Y, et al. Regulation of alternative splicing at the single-cell level[J]. Molecular Systems Biology, 2015, 11(12):845.
[77] TSAO A E, EDDINGER T J.Smooth muscle myosin heavy chains combine to form three native myosin isoforms[J]. The American Journal of Physiology, 1993, 264(5 Pt2):H1653-H1662.
[78] EDDINGER T J, KORWEK A A, MEER D P, et al. Expression of smooth muscle myosin light chain 17 and unloaded shortening in single smooth muscle cells[J]. American Journal of Physiology.Cell Physiology, 2000, 278(6):C1133-C1142.